Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (Q38805367)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 October 2016

Language	Label	Description	Also known as
English	Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms	scientific article published on 26 October 2016

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (English)

1 reference

Europe PubMed Central

6 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hannelore Ehrenreich

5

object named as

Hannelore Ehrenreich

0 references

Juliana Minardi Nascimento

object named as

Juliana M Nascimento

20

0 references

object named as

Johann Steiner

23

0 references

Edna Grünblatt

object named as

Edna Grünblatt

11

0 references

object named as

Andrea Schmitt

1

0 references

object named as

Peter Falkai

27

0 references

Daniel Martins-de-Souza

object named as

Daniel Martins-de-Souza

2

0 references

Johannes Kornhuber

17

object named as

Johannes Kornhuber

1 reference

Europe PubMed Central

6 September 2017

13

object named as

Alkomiet Hasan

1 reference

Europe PubMed Central

6 September 2017

Wagner Farid Gattaz

8

object named as

Wagner F Gattaz

1 reference

Europe PubMed Central

6 September 2017

26

object named as

Peter Riederer

1 reference

Europe PubMed Central

6 September 2017

author name string

Schahram Akbarian

3

1 reference

Europe PubMed Central

6 September 2017

Juliana S Cassoli

4

1 reference

Europe PubMed Central

6 September 2017

Andre Fischer

6

1 reference

Europe PubMed Central

6 September 2017

Alfred Fonteh

7

1 reference

Europe PubMed Central

6 September 2017

Michael Gawlik

9

1 reference

Europe PubMed Central

6 September 2017

Manfred Gerlach

10

1 reference

Europe PubMed Central

6 September 2017

Tobias Halene

12

1 reference

Europe PubMed Central

6 September 2017

Kenij Hashimoto

14

1 reference

Europe PubMed Central

6 September 2017

Yong-Ku Kim

15

1 reference

Europe PubMed Central

6 September 2017

Sophie-Kathrin Kirchner

16

1 reference

Europe PubMed Central

6 September 2017

Theo F J Kraus

18

1 reference

Europe PubMed Central

6 September 2017

Berend Malchow

19

1 reference

Europe PubMed Central

6 September 2017

Moritz Rossner

21

1 reference

Europe PubMed Central

6 September 2017

Markus Schwarz

22

1 reference

Europe PubMed Central

6 September 2017

Leda Talib

24

1 reference

Europe PubMed Central

6 September 2017

Florence Thibaut

25

1 reference

Europe PubMed Central

6 September 2017

Members of the WFSBP Task Force on Biological Markers

28

1 reference

Europe PubMed Central

6 September 2017

publication date

26 October 2016

1 reference

Europe PubMed Central

6 September 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

6 September 2017

18

1 reference

Europe PubMed Central

6 September 2017

330-356

1 reference

Europe PubMed Central

6 September 2017

5

1 reference

Europe PubMed Central

6 September 2017

DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Role of Lipids in Brain Injury and Diseases

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetic regulation in human brain-focus on histone lysine methylation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The molecular pathology of schizophrenia--focus on histone and DNA modifications

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Nuclear calcium signalling in the regulation of brain function

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Autoimmune diseases and infections as risk factors for schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Bioactive lipids in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Hypomethylation of the paternally inherited LRRTM1 promoter linked to schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Phospholipase A2 structure/function, mechanism, and signaling

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Kynurenines in CNS disease: regulation by inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Male-specific association between dopamine receptor D4 gene methylation and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Seroprevalence of autoantibodies against brain antigens in health and disease.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerations

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Losing your nerves? Maybe it's the antibodies

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Isoprostenes as indicators of oxidative stress in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased brain membrane fluidity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Recovery of learning and memory is associated with chromatin remodelling

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Toward the identification of peripheral epigenetic biomarkers of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Myelination, oligodendrocytes, and serious mental illness

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Lipopolysaccharide-induced immune activation impairs attention but has little effect on short-term working memory

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Schizophrenia: The role of abnormal essential fatty acid and prostaglandin metabolism

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

CSF metabolic and proteomic profiles in patients prodromal for psychosis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Perspective: Revealing molecular secrets.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Schizophrenia: treatment targets beyond monoamine systems

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

MicroRNAs in neuronal function and dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Medicine. Brain disorders? Precisely.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Neurophysiological biomarkers for drug development in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Effect of risperidone on serum cytokines

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Th1, Th2 and Th3 cytokine alteration in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

DNA methylation signatures of peripheral leukocytes in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Inflammation and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

When less is more--microRNAs and psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Chromatin modifications and their function

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetics as a basis for diagnosis of neurodevelopmental disorders: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Refinement of schizophrenia GWAS loci using methylome-wide association data

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Biochemistry and physiology of mammalian secreted phospholipases A2.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Schizophrenia: from dopaminergic to glutamatergic interventions

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cytosolic phospholipase A2 (cPLA2) distribution in murine brain and functional studies indicate that cPLA2 does not participate in muscarinic receptor-mediated signaling in neurons.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Inflammation in schizophrenia: A question of balance.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

DNA methylation patterns of protein coding genes and long noncoding RNAs in female schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Methylation patterns in whole blood correlate with symptoms in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Altered immune function in unaffected first-degree biological relatives of schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteome analysis of schizophrenia brain tissue

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteomic approaches to unravel the complexity of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteomics as a tool for understanding schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteomics tackling schizophrenia as a pathway disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Biomarkers for psychiatric disorders: where are we standing?

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Analytical tools and current challenges in the modern era of neuroepigenomics

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Anti-inflammatory treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Myelination and oligodendrocyte functions in psychiatric diseases

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Changes in gene expression and methylation in the blood of patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

MicroRNAs as biomarkers for CNS disease

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

De novo rates and selection of schizophrenia-associated copy number variants

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Phospholipid and eicosanoid signaling disturbances in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A role for noncoding variation in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Lipids of nervous tissue: composition and metabolism

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Inhibition of phospholipase A₂ in rat brain modifies different membrane fluidity parameters in opposite ways.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The phospholipase A2 superfamily and its group numbering system

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Biological insights from 108 schizophrenia-associated genetic loci

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The impact of environmental factors in severe psychiatric disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Neurobiology of schizophrenia: new findings from the structure to the molecules

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Altered thalamic membrane phospholipids in schizophrenia: a postmortem study

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Kynurenines in the mammalian brain: when physiology meets pathology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Pro-resolving lipid mediators are leads for resolution physiology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Phospholipase A2 activity is associated with structural brain changes in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Cytokines mediated inflammation and decreased neurogenesis in animal models of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Genetic architectures of psychiatric disorders: the emerging picture and its implications

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The immunopathogenesis of paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Examining peripheral DNA methylation in behavioral epigenetic and epigenetic psychiatry: opportunities and challenges.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Indomethacin induced psychosis

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Distribution of lipids in human brain

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Biomarkers of oxidative stress in schizophrenic and control subjects.

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Phospholipase A2 enzymes

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Imprinting in the schizophrenia candidate gene GABRB2 encoding GABAA receptor β2 subunit

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet

1 reference

https://api.crossref.org/works/10.1080%2F15622975.2016.1224929

21 January 2018

Identifiers

10.1080/15622975.2016.1224929

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38805367&oldid=2103290797"